R. Castrignano

发表

A single-blind study of doxazosin in the treatment of mild-to-moderate essential hypertensive patients with concomitant noninsulin-dependent diabetes mellitus.

A. D'Angelo, G. Crepaldi, R. Castrignano, 1988, American heart journal.

Effect of doxazosin in mild to moderate hypertensive patients with insulin-dependent diabetes mellitus

L. Bonfante, A. D'Angelo, P. Davis, 1998, Acta Diabetologica.

Effects of one-year cyclical treatment with clodronate on postmenopausal bone loss.

S. Giannini, A. D'Angelo, G. Crepaldi, 1993, Bone.

Efficacy of captopril in hypertensive diabetic patients.

S. Giannini, A. D'Angelo, G. Crepaldi, 1988, The American journal of medicine.

Possible link between vitamin D and hyperoxaluria in patients with renal stone disease.

S. Giannini, A. D'Angelo, F. Pellegrini, 1993, Clinical science.

Role of insulin-like growth factor-I in primary osteoporosis: A correlative study

S. Giannini, A. D'Angelo, A. Semplicini, 2000, Journal of endocrinological investigation.

Is hydrochlorothiazide-induced hypocalciuria due to inhibition of prostaglandin E2 synthesis?

S. Giannini, G. Gambaro, A. D'Angelo, 1990, Clinical science.

Longitudinal study on osteodystrophy in primary biliary cirrhosis (PBC) and a pilot study on calcitonin treatment.

S. Giannini, A. D'Angelo, A. Floreani, 1991, Journal of hepatology.

Hyperparathyroidism: cause or consequence of recurrent calcium nephrolithiasis?

S. Giannini, A. Fabris, A. D'Angelo, 1992, Mineral and electrolyte metabolism.

Exogenous calcitonin protects against renal bone disease in rats with early renal failure.

S. Giannini, A. D'Angelo, E. Bonucci, 1987, Bone and mineral.

Modification in Renal Handling of Phosphate Induced by Hydrochlorothiazide (HCTZ) and Amiloride (A)

S. Giannini, A. Fabris, G. Crepaldi, 1987 .